Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Li, Chunguang ^a,c   Li, Zhigang ^a   Zhu, Maoling ^b   Zhao, Tiejun ^a   Chen, Ling ^a   Ji, Weidan ^c   Chen, Hezhong ^a   Su, Changqing ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATHOLOGY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SYSTEMATIC REVIEW;

CARCINOMA, SQUAMOUS CELL; CYTOPLASM; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; ODDS RATIO;

EID: 84866932017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044764     Document Type: Article

References (32)

1. Kamangar F, Dores GM, Anderson WF, (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
2. Akyurek N, Memis L, Ekinci O, Kokturk N, Ozturk C, (2006) Survivin expression in pre-invasive lesions and non-small cell lung carcinoma. Virchows Arch 449: 164-170.
3. Ambrosini G, Adida C, Altieri DC, (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921.
4. Nakashima N, Huang CL, Liu D, Ueno M, Yokomise H, (2010) Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer. Int J Oncol 37: 687-694.
5. Sohn DM, Kim SY, Baek MJ, Lim CW, Lee MH, et al. (2006) Expression of survivin and clinical correlation in patients with breast cancer. Biomed Pharmacother 60: 289-292.
6. Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, et al. (2007) Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 109: 1106-1113.
7. Yang Y, Zhu J, Gou H, Cao D, Jiang M, et al. (2011) Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). Med Oncol 28: 796-803.
8. Liu BB, Wang WH, (2011) Survivin and pancreatic cancer. World J Clin Oncol 2: 164-168.
9. Altieri DC, (2008) Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8: 61-70.
10. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, et al. (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320.
11. Stang A, (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-605.
12. Parmar MK, Torri V, Stewart L, (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17: 2815-2834.
13. Hsu KF, Lin CK, Yu CP, Tzao C, Lee SC, et al. (2009) Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. Dis Esophagus 22: 402-408.
14. Dabrowski A, Filip A, Zgodzinski W, Dabrowska M, Polanska D, et al. (2004) Assessment of prognostic significance of cytoplasmic survivin expression in advanced oesophageal cancer. Folia Histochem Cytobiol 42: 169-172.
15. Zhu H, Wang Q, Hu C, Zhang W, Quan L, et al. (2011) High expression of survivin predicts poor prognosis in esophageal squamous cell carcinoma following radiotherapy. Tumour Biol 32: 1147-1153.
16. Mega S, Miyamoto M, Li L, Kadoya M, Takahashi R, et al. (2006) Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. Dis Esophagus 19: 355-359.
17. Takeno S, Yamashita S, Takahashi Y, Ono K, Kamei M, et al. (2010) Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression. Eur J Cardiothorac Surg 37: 440-445.
18. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, Stein H, et al. (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88: 115-119.
19. Leonardi-Bee J, Smyth A, Britton J, Coleman T, (2008) Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 93: F351-361.
20. Wang L, Shao ZM, (2006) Cyclin e expression and prognosis in breast cancer patients: a meta-analysis of published studies. Cancer Invest 24: 581-587.
21. Nakamura H, Kawasaki N, Taguchi M, Kabasawa K, (2006) Survival impact of epidermal growth factor receptor overexpression in patients with non-small cell lung cancer: a meta-analysis. Thorax 61: 140-145.
22. Zhang LQ, Wang J, Jiang F, Xu L, Liu FY, et al. (2012) Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLoS One 7: e34100.
23. Fan J, Wang L, Jiang GN, He WX, Ding JA, (2008) The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures. Lung Cancer 61: 91-96.
24. Altieri DC, (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46-54.
25. Yang D, Welm A, Bishop JM, (2004) Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci U S A 101: 15100-15105.
26. Tran J, Rak J, Sheehan C, Saibil SD, LaCasse E, et al. (1999) Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun 264: 781-788.
27. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, et al. (2000) Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156: 393-398.
28. Tran J, Master Z, Yu JL, Rak J, Dumont DJ, et al. (2002) A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci U S A 99: 4349-4354.
29. Sah NK, Khan Z, Khan GJ, Bisen PS, (2006) Structural, functional and therapeutic biology of survivin. Cancer Lett 244: 164-171.
30. Ryan BM, O'Donovan N, Duffy MJ, (2009) Survivin: a new target for anti-cancer therapy. Cancer Treat Rev 35: 553-562.
31. Duffy MJ, O'Donovan N, Brennan DJ, Gallagher WM, Ryan BM, (2007) Survivin: a promising tumor biomarker. Cancer Lett 249: 49-60.
32. Ikeguchi M, Kaibara N, (2002) survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma. Br J Cancer 87: 883-887.